These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M Lee NR; Gujarathi S; Bommagani S; Siripurapu K; Zheng G; Dwoskin LP Bioorg Med Chem Lett; 2019 Feb; 29(3):471-476. PubMed ID: 30554957 [TBL] [Abstract][Full Text] [Related]
23. Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M Spearing PK; Cho HP; Luscombe VB; Blobaum AL; Boutaud O; Engers DW; Rodriguez AL; Niswender CM; Jeffrey Conn P; Lindsley CW; Bender AM Bioorg Med Chem Lett; 2021 Sep; 47():128193. PubMed ID: 34118412 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and SAR of selective muscarinic acetylcholine receptor subtype 1 (M1 mAChR) antagonists. Lewis LM; Sheffler D; Williams R; Bridges TM; Kennedy JP; Brogan JT; Mulder MJ; Williams L; Nalywajko NT; Niswender CM; Weaver CD; Conn PJ; Lindsley CW Bioorg Med Chem Lett; 2008 Feb; 18(3):885-90. PubMed ID: 18178088 [TBL] [Abstract][Full Text] [Related]
25. Further optimization of the M1 PAM VU0453595: Discovery of novel heterobicyclic core motifs with improved CNS penetration. Panarese JD; Cho HP; Adams JJ; Nance KD; Garcia-Barrantes PM; Chang S; Morrison RD; Blobaum AL; Niswender CM; Stauffer SR; Conn PJ; Lindsley CW Bioorg Med Chem Lett; 2016 Aug; 26(15):3822-5. PubMed ID: 27173801 [TBL] [Abstract][Full Text] [Related]
26. Isatin replacements applied to the highly selective, muscarinic M1 PAM ML137: continued optimization of an MLPCN probe molecule. Melancon BJ; Poslusney MS; Gentry PR; Tarr JC; Sheffler DJ; Mattmann ME; Bridges TM; Utley TJ; Daniels JS; Niswender CM; Conn PJ; Lindsley CW; Wood MR Bioorg Med Chem Lett; 2013 Jan; 23(2):412-6. PubMed ID: 23237839 [TBL] [Abstract][Full Text] [Related]
27. Development of a highly potent, novel M5 positive allosteric modulator (PAM) demonstrating CNS exposure: 1-((1H-indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380). Gentry PR; Kokubo M; Bridges TM; Noetzel MJ; Cho HP; Lamsal A; Smith E; Chase P; Hodder PS; Niswender CM; Daniels JS; Conn PJ; Lindsley CW; Wood MR J Med Chem; 2014 Sep; 57(18):7804-10. PubMed ID: 25147929 [TBL] [Abstract][Full Text] [Related]
28. Muscarinic receptor subtypes are differentially distributed in the rat cochlea. Khan KM; Drescher MJ; Hatfield JS; Khan AM; Drescher DG Neuroscience; 2002; 111(2):291-302. PubMed ID: 11983315 [TBL] [Abstract][Full Text] [Related]
29. Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core. Wood MR; Noetzel MJ; Engers JL; Bollinger KA; Melancon BJ; Tarr JC; Han C; West M; Gregro AR; Lamsal A; Chang S; Ajmera S; Smith E; Chase P; Hodder PS; Bubser M; Jones CK; Hopkins CR; Emmitte KA; Niswender CM; Wood MW; Duggan ME; Conn PJ; Bridges TM; Lindsley CW Bioorg Med Chem Lett; 2016 Jul; 26(13):3029-3033. PubMed ID: 27185330 [TBL] [Abstract][Full Text] [Related]
30. Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators. Berizzi AE; Gentry PR; Rueda P; Den Hoedt S; Sexton PM; Langmead CJ; Christopoulos A Mol Pharmacol; 2016 Oct; 90(4):427-36. PubMed ID: 27461343 [TBL] [Abstract][Full Text] [Related]
34. Challenges in the development of an M Tarr JC; Wood MR; Noetzel MJ; Bertron JL; Weiner RL; Rodriguez AL; Lamsal A; Byers FW; Chang S; Cho HP; Jones CK; Niswender CM; Wood MW; Brandon NJ; Duggan ME; Conn PJ; Bridges TM; Lindsley CW Bioorg Med Chem Lett; 2017 Jul; 27(13):2990-2995. PubMed ID: 28522253 [TBL] [Abstract][Full Text] [Related]
35. Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM. Bridges TM; Kennedy JP; Cho HP; Breininger ML; Gentry PR; Hopkins CR; Conn PJ; Lindsley CW Bioorg Med Chem Lett; 2010 Jan; 20(2):558-62. PubMed ID: 20004578 [TBL] [Abstract][Full Text] [Related]
36. Muscarinic acetylcholine receptor (mAChR) inhibitor from snake venom: interaction with subtypes of human mAChR. Miyoshi S; Tu AT Arch Biochem Biophys; 1999 Sep; 369(1):114-8. PubMed ID: 10462446 [TBL] [Abstract][Full Text] [Related]
37. Challenges in the development of an M Wood MR; Noetzel MJ; Poslusney MS; Melancon BJ; Tarr JC; Lamsal A; Chang S; Luscombe VB; Weiner RL; Cho HP; Bubser M; Jones CK; Niswender CM; Wood MW; Engers DW; Brandon NJ; Duggan ME; Conn PJ; Bridges TM; Lindsley CW Bioorg Med Chem Lett; 2017 Jan; 27(2):171-175. PubMed ID: 27939174 [TBL] [Abstract][Full Text] [Related]
38. Discovery and SAR of a novel series of GIRK1/2 and GIRK1/4 activators. Ramos-Hunter SJ; Engers DW; Kaufmann K; Du Y; Lindsley CW; Weaver CD; Sulikowski GA Bioorg Med Chem Lett; 2013 Sep; 23(18):5195-8. PubMed ID: 23916258 [TBL] [Abstract][Full Text] [Related]
39. Human skin fibroblasts express m2, m4, and m5 subtypes of muscarinic acetylcholine receptors. Buchli R; Ndoye A; Rodriguez JG; Zia S; Webber RJ; Grando SA J Cell Biochem; 1999 Aug; 74(2):264-77. PubMed ID: 10404395 [TBL] [Abstract][Full Text] [Related]